Correlation Engine 2.0
Clear Search sequence regions


  • adult (1)
  • breast lesion (12)
  • breast neoplasms (1)
  • female (1)
  • humans (1)
  • patients (3)
  • tumor burden (1)
  • vacuum (12)
  • Sizes of these terms reflect their relevance to your search.

    This study aims to compare the feasibility of VAE and BLES in the treatment of intraductal papillomas. Patients with a suspected intraductal papilloma who underwent a BLES or a VAE procedure were included in this retrospective study. The BLES procedures were performed between November 2011 and June 2016 and the VAE procedures between May 2018 and September 2020 at the Department of Radiology of Helsinki University Hospital (HUH). The procedures were performed with an intent of complete removal of the lesions. In total, 72 patients underwent 78 BLES procedures and 95 patients underwent 99 VAE procedures. Altogether 52 (60%) papillomas with or without atypia were completely removed with VAE, whereas 24 (46%) were completely removed with BLES, p = 0.115. The median radiological size of the high-risk lesions completely removed with BLES was 6 mm (4-12 mm), whereas with VAE it was 8 mm (3-22 mm), p = 0.016. Surgery was omitted in 90 (94.7%) non-malignant breast lesions treated with VAE and in 66 (90.4%) treated with BLES, p = 0.368. Both VAE and BLES were feasible in the treatment of intraductal papillomas. In most non-malignant lesions surgery was avoided, but VAE was feasible in larger lesions than BLES. However, follow-up ultrasound was needed more often after VAE. The histopathologic assessment is more reliable after BLES, as the lesion is removed as a single sample. Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

    Citation

    Michaela Björnström, Laura Niinikoski, Tuomo J Meretoja, Marjut H K Leidenius, Katja Hukkinen. Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2022 Jan;48(1):67-72

    Expand section icon Mesh Tags


    PMID: 34728140

    View Full Text